03.01.2024

Clinical Microbiomics adds World-Leading Expertise in Long-Read DNA & RNA Sequencing Technologies with Acquisition of DNASense ApS

Copenhagen, Denmark, March 1st, 2024 – Clinical Microbiomics A/S1, the global microbiome science company, today announces the acqu...

Read the full story
10.11.2023

Clinical Microbiomics A/S and CosmosID Inc. Merge to Create the Global Leader in Microbiome Research Services

Copenhagen, Denmark, October 11th, 2023 – Clinical Microbiomics A/S, a leading innovator in bioinformatics and systems biology for...

Read the full story
09.20.2023

Introducing our next generation human microbiome profiler: CHAMP™

CHAMP™ is built from over 400,000 metagenome-assembled genomes (MAGs), created using a collection of more than 30,000 microbiome sam...

Read the full story
08.07.2023

New article in the Microbiome Times

“The term “strain” has, in the microbiome era, drifted away from its original meaning of an isolate that had been “strained” on a growth medium. It now refers to a clonal population, including those found in our microbiomes...

Read the full story
06.21.2023

Clinical Microbiomics at the IPC congress

Our colleagues Jessica Lin, Grace Barker, PhD, and Gustav Lindved are attending the International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health (IPC) in Bratislava, Slovakia.

Read the full story
06.08.2023

Clinical Microbiomics sponsored the FinnBrain Congress

At Clinical Microbiomics, we are committed to helping researchers find new ways to impact health and disease and the gut-brain axis is an area of increasingly high interest.

Read the full story
05.23.2023

Clinical Microbiomics at the Microbiome Forum 2023

This week, our team was attending the Microbiome Forum in Rotterdam. We gave two presentations on submission-ready microbiome data for...

Read the full story
05.22.2023

New publication in Nature Microbiology

We are proud to share new research by our colleague, Joachim Johansen, PhD and his former colleagues at the Broad Institute of MIT and Harvard, published in Nature Microbiology last week.

Read the full story
05.18.2023

Clinical Microbiomics at ESPGHAN 2023

This week, our team was attending the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) congress in Vienna.

Read the full story
05.03.2023

Clinical Microbiomics at OCT Europe 2023

This week, Marianne, our VP of Business Development, was attending Outsourcing In Clinical Trials (OCT) Europe 2023: a leading event connecting...

Read the full story
04.27.2023

FDA approval of the first orally administered fecal microbiota product

Last night, the FDA approved Vowst, the first orally-administered fecal microbiota product for the prevention of recurrent C. difficile infection. This marks a new milestone for the microbiome field, but most importantly, for patients. 

Read the full story
04.26.2023

New publication in Chest Journal

The world’s most comprehensive population-based study investigating the relationship of obstructive sleep apnea (OSA) with the human gut microbiota has just been published in Chest by Uppsala University, Lund University, the University of Gothenburg and Clinical Microbiomics.

Read the full story
04.18.2023

Clinical Microbiomics at ECCMID 2023

Our team was attending the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) this week in Copenhagen. We enjoyed discussing how our metagenomics and metabolomics analysis solutions can support infectious disease clinical studies.

Read the full story
04.17.2023

Clinical Microbiomics at the Translational Microbiome Conference

Our CSO, Dr. H. Bjørn Nielsen, together with Heidi Hau, PhD, our VP Scientific Affairs & Partnerships, were attending the 8th Annual Translational Microbiome Conference this week in Washington DC.

Read the full story
03.01.2023

Meet our new colleagues: Jakob, Maria, and William

Our company keeps developing and we are onboarding three new talents: Jakob, Maria, and William. We are thrilled to be joined by talented individuals, who share our passion for microbiome science.

Read the full story
02.11.2023

Happy International day of Women and Girls in Science

Today, 11th of February, marks the International Day of Women and Girls in Science – a good occasion for all of us to support and promote equal access and participation of women in STEM. At Clinical Microbiomics, diversity is indispensable...

Read the full story
01.27.2023

Our presentation at the Precision Medicine World Conference

This week Heidi Hau, PhD, our VP Scientific Affairs & Partnerships was attending the Precision Medicine World Conference, presenting our clonal-level microbiome profiling platform.

Read the full story
01.25.2023

New publication in Nature Biotechnology

In a new study published in Nature Biotechnology, a team of European scientists explored deep-learning models to solve the complexity of omics datasets for discovering drug-omics associations in type 2 diabetes.

Read the full story
01.11.2023

Heidi Hau, PhD, joins our team as Vice President Scientific Affairs & Partnerships

We are beyond excited to announce that Heidi Hau, PhD, has joined our team to lead the expansion of our US Business.

Read the full story
12.22.2022

Reflecting upon 2023

What a year for microbiome science! The festive season is a good opportunity to highlight and reflect on some of the great achievements by our team and the microbiome community as a whole...

Read the full story
12.15.2022

Meet our new colleagues: Alexander, Maja, and Joachim

We recently welcomed three talented new colleagues in our team. Meet Alexander, Maja, and Joachim! We are proud to see our team growing...

Read the full story
12.02.2022

FDA approval of the first fecal microbiota product

Our CSO H. Bjørn Nielsen shares his perspective on this incredible news.

Read the full story
11.21.2022

Attending Microbiome Connect in Boston

Last week our colleagues Marianne Koliana and Gustav Lindved attended the Microbiome Connect Conference in Boston. A particularly i...

Read the full story
11.15.2022

New publication in BMC Microbiome

In a recent paper, published in BMC Microbiome, we used our clonal-level metagenomics technology to investigate cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation (FMT) to a pregnant patient with Clostridioides difficile infection (CDI).

Read the full story
11.11.2022

Clinical Microbiomics at IHMC 2022

IHMC is considered the leading forum for microbiome science, gathering hundreds of renowned scientists and researchers from both academia and industry.

Read the full story
11.01.2022

New publication in Nature Communications

New study is paving the way towards a better understanding of the influence of the gut microbiome on human health via plasma metabolites.

Read the full story
10.17.2022

Clinical Microbiomics acquires MS-Omics

Following our acquisition of MS-Omics, we add metabolomics to our portfolio. We now form the leading multi-omics provider for the microbiome field.

Read the full story
10.11.2022

Clinical Microbiomics receives EUR 10M investment from Seventure Partners

We are proud to announce the completion of a 10M EUR investment from Seventure Partners.

Read the full story
09.07.2022

New publication in Frontiers in Nutrition

Using shotgun metagenomic sequencing and untargeted mass spectrometry metabolomics, we measured the microbiota composition and 743 known biochemical species in infant stool at 3 months of age...

Read the full story
07.14.2022

New publication in Frontiers in Nutrition

The study investigated the effects of an infant formula containing a specific blend of five HMOs (2′-FL, DFL, LNT, 3′-SL, and 6′-SL) by analyzing the gut microbiota of...

Read the full story
06.25.2022

Clinical Microbiomics at ESPGHAN 2022

Our team was delighted to attend the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutriti...

Read the full story
06.01.2022

New publication in Nutrients

This study investigated the effects of an amino acid-based formula supplemented with two Human Milk Oligosaccharides (2’-FL and LNnT) on growth, tolerability, safety, and gut microbiome in infants with Cow’s Milk Protein Allergy (CMPA). 

Read the full story
10.01.2021

Anders Grøn joins Clinical Microbiomics as new CEO

Anders Grøn comes from a position as Group Vice President of IFF (prev. Dupont), and global leader for IFF Health.

Read the full story

Get in touch

Tell us about your study.

Please enable JavaScript in your browser to complete this form.
=